Bionano Genomics Inc.

5.27-0.3900-6.89%Vol 18.63M1Y Perf 1 411.43%
Apr 19th, 2021 16:00 DELAYED
BID5.26 ASK5.27
Open5.44 Previous Close5.66
Pre-Market- After-Market-
 - -  - -%
Target Price
14.33 
Analyst Rating
Strong Buy 1.00
Potential %
171.92 
Finscreener Ranking
★★★     51.01
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.83
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     44.95
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap1.47B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
32.16 
Earnings Date
23rd Mar 2021

Today's Price Range

5.125.70

52W Range

0.330015.69

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-23.51%
1 Month
-41.64%
3 Months
-34.53%
6 Months
853.16%
1 Year
1 411.43%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BNGO5.27-0.3900-6.89
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Financial StrengthValueIndustryS&P 500US Markets
4.60
5.20
0.32
0.47
-15.30
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
32.60
-474.40
-457.70
-288.60
-
RevenueValueIndustryS&P 500US Markets
7.37M
0.03
-5.05
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.06-0.060.00
Q03 2020-0.06-0.08-33.33
Q02 2020-0.09-0.090.00
Q01 2020-0.22-0.30-36.36
Q03 2019-0.57-0.59-3.51
Q02 2019-0.57-0.71-24.56
Q01 2019-0.56-0.68-21.43
Q04 2018-0.48-0.62-29.17
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.0528.57Positive
6/2021 QR-0.0528.57Positive
12/2021 FY-0.1913.64Positive
12/2022 FY-0.24-26.32Negative
Next Report Date-
Estimated EPS Next Report-0.05
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume18.63M
Shares Outstanding278.66M
Trades Count74.72K
Dollar Volume236.84M
Avg. Volume58.96M
Avg. Weekly Volume20.07M
Avg. Monthly Volume17.91M
Avg. Quarterly Volume35.69M

Bionano Genomics Inc. (NASDAQ: BNGO) stock closed at 5.27 per share at the end of the most recent trading day (a -6.89% change compared to the prior day closing price) with a volume of 18.81M shares and market capitalization of 1.47B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 97 people. Bionano Genomics Inc. CEO is Mark Adamchak.

The one-year performance of Bionano Genomics Inc. stock is 1411.43%, while year-to-date (YTD) performance is 71.1%. BNGO stock has a five-year performance of %. Its 52-week range is between 0.33 and 15.69, which gives BNGO stock a 52-week price range ratio of 32.16%

Bionano Genomics Inc. currently has a PE ratio of -10.90, a price-to-book (PB) ratio of 44.96, a price-to-sale (PS) ratio of 199.34, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -88.08%, a ROC of -164.45% and a ROE of -210.71%. The company’s profit margin is -%, its EBITDA margin is -457.70%, and its revenue ttm is $7.37 Million , which makes it $0.03 revenue per share.

Of the last four earnings reports from Bionano Genomics Inc., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. Bionano Genomics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Bionano Genomics Inc. is Strong Buy (1), with a target price of $14.33, which is +171.92% compared to the current price. The earnings rating for Bionano Genomics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bionano Genomics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bionano Genomics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 26.19, ATR14 : 1.23, CCI20 : -194.90, Chaikin Money Flow : -0.23, MACD : -1.18, Money Flow Index : 24.16, ROC : -34.78, RSI : 38.99, STOCH (14,3) : 4.53, STOCH RSI : 0.00, UO : 33.09, Williams %R : -95.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bionano Genomics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

CEO: Mark Adamchak

Telephone: +1 858 888-7600

Address: 9540 Towne Centre Drive, San Diego 92121, CA, US

Number of employees: 97

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

News

Stocktwits